Cargando…
Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors
Multitarget drugs are a promising therapeutic approach against Alzheimer’s disease. In this work, a new family of 5-substituted indazole derivatives with a multitarget profile including cholinesterase and BACE1 inhibition is described. Thus, the synthesis and evaluation of a new class of 5-substitut...
Autores principales: | González-Naranjo, Pedro, Pérez, Concepción, González-Sánchez, Marina, Gironda-Martínez, Adrián, Ulzurrun, Eugenia, Bartolomé, Fernando, Rubio-Fernández, Marcos, Martin-Requero, Angeles, Campillo, Nuria E., Páez, Juan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477487/ https://www.ncbi.nlm.nih.gov/pubmed/36050834 http://dx.doi.org/10.1080/14756366.2022.2117315 |
Ejemplares similares
-
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease
por: Ponzoni, Ignacio, et al.
Publicado: (2019) -
Multitarget Hybrid
Fasudil Derivatives as a New Approach
to the Potential Treatment of Amyotrophic Lateral Sclerosis
por: Martín-Cámara, Olmo, et al.
Publicado: (2022) -
Metal-free regioselective mono- and poly-halogenation of 2-substituted indazoles
por: Zhang, Changjun, et al.
Publicado: (2023) -
Multitarget Approach to Drug Candidates against Alzheimer’s Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets
por: Ivanova, Larisa, et al.
Publicado: (2020) -
New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease
por: García Marín, Iohanan Daniel, et al.
Publicado: (2022)